Life Science Market Reports

May-2012

SynopsisIndian neonatal ventilator market in India is poised to grow at a healthy rate as more and more hospitals and nursing homes develop specialized child care units. Also, the budget allocation towards the overall healthcare sector is also in an increasing mode resulting in better infrastructural facilities all across the country. The report begins with an introduction to the overall ventilator market and defines the scope of the report. It explains the features ...
View More

May-2012

SynopsisIndian ventilator market in India is poised to grow at a healthy rate as more and more hospitals and nursing homes develop specialized intensive care units. Also, as the life expectancy rate is increasing so ventilators would be more in use to treat elderly patients.The report begins with an introduction which explains the salient features of ventilators and its usefulness. Also, the report explains the various types of ventilators in the market. In the mark ...
View More

May-2012

SynopsisIndian ventilator market in India is poised to grow at a healthy rate as more and more hospitals and nursing homes develop specialized intensive care units. Also, as the life expectancy rate is increasing so ventilators would be more in use to treat elderly patients. The report begins with an introduction which explains the salient features of ventilators and its usefulness. Also, the report explains the various types of ventilators in the market. In the ma ...
View More

Apr-2012

SynopsisThe Indian clinical trials market is growing at an excellent rate and currently witnessing a large number of global pharmaceutical companies outsourcing trials to contract research organizations (CROs) in India. This is largely due to the country’s lower costs and various other advantages. Moreover, many domestic pharmaceutical companies as well have increased their R&D spending for new drug development and are outsourcing clinical trials to various CROs. W ...
View More

Apr-2012

SynopsisThe Indian clinical trials market is growing at an excellent rate and currently witnessing a large number of global pharmaceutical companies outsourcing trials to contract research organizations (CROs) in India. This is largely due to the country’s lower costs and various other advantages. Moreover, many domestic pharmaceutical companies as well have increased their R&D spending for new drug development and are outsourcing clinical trials to various CROs. W ...
View More

Apr-2012

SynopsisOncology pharmaceuticals market in India, a leading segment of the overall pharmaceuticals market is the fourth largest in volume and eighth largest in value in the global market. Since cancer is the second largest cause of death in the country, the Indian market is characterized by a huge demand for cancer drugs. It is a highly fragmented market with a large number of foreign and domestic players. The huge increase in the number of cancer cases, specially ...
View More

Apr-2012

SynopsisCardiovascular pharmaceuticals market in India is the second largest contributor to domestic pharmaceutical sales, contributing around 15.6%. Since India has a huge patient pool, the Indian market is characterized by a huge demand for cardiovascular drugs. It is a highly fragmented market with a large number of foreign and domestic players. The huge increase in the patient population, patent expiry of popular blockbuster drugs, increase in disposable income ...
View More

Apr-2012

SynopsisOncology pharmaceuticals market in India, a leading segment of the overall pharmaceuticals market is the fourth largest in volume and eighth largest in value in the global market. Since cancer is the second largest cause of death in the country, the Indian market is characterized by a huge demand for cancer drugs. It is a highly fragmented market with a large number of foreign and domestic players. The huge increase in the number of cancer cases, specially ...
View More

Apr-2012

SynopsisCardiovascular pharmaceuticals market in India is the second largest contributor to domestic pharmaceutical sales, contributing around 15.6%. Since India has a huge patient pool, the Indian market is characterized by a huge demand for cardiovascular drugs. It is a highly fragmented market with a large number of foreign and domestic players. The huge increase in the patient population, patent expiry of popular blockbuster drugs, increase in disposable income ...
View More